What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Virus
- Cancer
His scientific interests lie mostly in Hepatitis C, Internal medicine, Hepatitis C virus, Gastroenterology and Cirrhosis.
Alfredo Alberti interconnects Burden of disease, Epidemiology and Bioinformatics in the investigation of issues within Hepatitis C.
The various areas that Alfredo Alberti examines in his Internal medicine study include Pegylated interferon and Surgery.
His Hepatitis C virus research entails a greater understanding of Immunology.
His Immunology study frequently involves adjacent topics like Virology.
Alfredo Alberti has included themes like Fibrosis, Biopsy, Peginterferon alfa-2a and Confidence interval in his Gastroenterology study.
His most cited work include:
- Management of hepatitis C. (392 citations)
- Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C (246 citations)
- Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy (220 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Virology, Immunology, Gastroenterology and Hepatitis C virus.
His study in Hepatitis C and Cirrhosis is carried out as part of his studies in Internal medicine.
His Hepatitis C research is multidisciplinary, incorporating elements of Liver transplantation and Alpha interferon.
Alfredo Alberti usually deals with Immunology and limits it to topics linked to Liver disease and Chronic liver disease, Pathology and Hepatology.
His work carried out in the field of Gastroenterology brings together such families of science as Fibrosis, Regimen and Biopsy, Liver biopsy.
His Hepatitis B virus research includes themes of Hepatitis B and Antigen.
He most often published in these fields:
- Internal medicine (42.00%)
- Virology (37.47%)
- Immunology (35.80%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (42.00%)
- Hepatitis C (25.78%)
- Gastroenterology (30.79%)
In recent papers he was focusing on the following fields of study:
Alfredo Alberti focuses on Internal medicine, Hepatitis C, Gastroenterology, Virology and Ribavirin.
His biological study spans a wide range of topics, including Surgery and Oncology.
His Hepatitis C study combines topics in areas such as Liver transplantation, Cirrhosis, Intensive care medicine, Liver disease and Hepatology.
His Cirrhosis research incorporates elements of Fibrosis and Liver biopsy.
He has researched Gastroenterology in several fields, including Esophageal adenocarcinoma, Hepatitis and Genotype, Hepacivirus.
His Hepatitis C virus, Hepatitis B virus and Alisporivir investigations are all subjects of Virology research.
Between 2011 and 2021, his most popular works were:
- Cost-effectiveness of boceprevir or telaprevir for previously treated patients with genotype 1 chronic hepatitis C (105 citations)
- Newly diagnosed hepatocellular carcinoma in patients with advanced hepatitis C treated with DAAs: A prospective population study. (58 citations)
- How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C (41 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Virus
- Cancer
Internal medicine, Hepatitis C, Ribavirin, Liver disease and Hepatitis C virus are his primary areas of study.
His work deals with themes such as Gastroenterology, Viral load and Oncology, which intersect with Internal medicine.
His Gastroenterology research incorporates themes from Alisporivir and Immunology.
His Hepatitis C research includes elements of Liver transplantation, Surgery, Hepatology, Cirrhosis and Hepatocellular carcinoma.
Alfredo Alberti combines subjects such as Coinfection and Alpha interferon with his study of Liver disease.
Hepatitis C virus is a subfield of Virology that Alfredo Alberti explores.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
